Preview Party: August 22, 2013 Show: August 23 through August 25, 2013 Proceeds from ACE will support
ovarian cancer research at NorthShore.
Not exact matches
Kelly and accomplished master baker and cake decorator Buddy Valastro, from TLC's «Cake Boss,» recently joined forces
at a fun event to bake lavishly decorated cakes in support of The
Ovarian Cancer Research...
Her work in protein
research at Hunter and her grandmother's recent diagnosis of
ovarian cancer sparked an interest in
cancer biology and immunology, but Rezende is eager to sample other fields.
Scientists
at Lawson Health
Research Institute have uncovered an important new target for
ovarian cancer therapy.
Funding for the study was provided by the National Institutes of Health (P50 CA083638, R21 CA156224, 5P30 CA016520 - 36), the Marcus Foundation, the
Ovarian Cancer Immunotherapy Initiative, the Ludwig Institute for
Cancer Research at the University of Lausanne, and the Ovacure Foundation.
«While the presence of lymphocytes in tumors is often associated with better clinical outcomes, this
research adds clarity on the diversity of T cells within the tumor environment and their influence on
ovarian cancer outcomes,» says first author Kunle Odunsi, MD, PhD, FRCOG, FACOG, Deputy Director, M. Steven Piver Professor and Chair of Gynecologic Oncology, and Executive Director of the Center for Immunotherapy
at Roswell Park.
«What we've discovered will help clinicians to better treat women with
ovarian cancer,» says Dr. Ben Tsang, senior scientist
at the Ottawa Hospital
Research Institute and professor
at the University of Ottawa.
Researchers using data collected by the
Ovarian Cancer Association Consortium have discovered uncommon variants in new regions of the genome that influence ovarian cancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San Die
Ovarian Cancer Association Consortium have discovered uncommon variants in new regions of the genome that influence ovarian cancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San Dieg
Cancer Association Consortium have discovered uncommon variants in new regions of the genome that influence
ovarian cancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San Die
ovarian cancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San Dieg
cancer risk, and will present their findings on April 6, 2014
at the American Association for
Cancer Research Annual Meeting in San Dieg
Cancer Research Annual Meeting in San Diego, CA.
A Mayo Clinic
research team has found evidence suggesting that the controversial practice of ovary removal in premenopausal women to prevent
ovarian cancer should be discontinued in women who are not
at high risk of
cancer.
The lab of co-author Dr. Robert Bast Jr., an expert in
ovarian cancer and vice president for translational
research at MD Anderson, inserted gel - bound carbon nanotubes into the ovaries of rodents to mimic the accumulations that are expected for nanotubes linked to special antibodies that recognize tumor cells.
«By combining my laboratory's expertise in
ovarian cancer biology and Dr. Xu's expertise in bioinformatics, we were able to uncover a potentially novel drug approach to treat ovarian cancer,» said co-senior author Analisa DiFeo, PhD, the Norma C. and Albert I. Geller Designated Professor of Ovarian Cancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of Me
ovarian cancer biology and Dr. Xu's expertise in bioinformatics, we were able to uncover a potentially novel drug approach to treat ovarian cancer,» said co-senior author Analisa DiFeo, PhD, the Norma C. and Albert I. Geller Designated Professor of Ovarian Cancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of Med
cancer biology and Dr. Xu's expertise in bioinformatics, we were able to uncover a potentially novel drug approach to treat
ovarian cancer,» said co-senior author Analisa DiFeo, PhD, the Norma C. and Albert I. Geller Designated Professor of Ovarian Cancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of Me
ovarian cancer,» said co-senior author Analisa DiFeo, PhD, the Norma C. and Albert I. Geller Designated Professor of Ovarian Cancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of Med
cancer,» said co-senior author Analisa DiFeo, PhD, the Norma C. and Albert I. Geller Designated Professor of
Ovarian Cancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of Me
Ovarian Cancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of Med
Cancer Research and assistant professor in the Case Comprehensive
Cancer Center at Case Western Reserve University School of Med
Cancer Center
at Case Western Reserve University School of Medicine.
Technology developed
at Western University and Lawson Health
Research Institute can provide a new window into whether or not patients are responding to treatment for advanced
ovarian cancer.
Now a team led by Lin Zhang, PhD,
research associate professor in the Department of Obstetrics and Gynecology
at the Perelman School of Medicine
at the University of Pennsylvania, has mined those sequences to identify a non-protein-coding RNA whose expression is linked to
ovarian cancer.
Nearly 20 percent of women with
ovarian cancer do not undergo surgery, despite it being a standard part of treatment recommendations, according to new
research from the Perelman School of Medicine
at the University of Pennsylvania.
Dr James Brenton,
Cancer Research UK's ovarian cancer expert, says: «A blood test to find women at risk of ovarian cancer is an exciting prospect, but this work still needs to be tested in women to see if it can save
Cancer Research UK's
ovarian cancer expert, says: «A blood test to find women at risk of ovarian cancer is an exciting prospect, but this work still needs to be tested in women to see if it can save
cancer expert, says: «A blood test to find women
at risk of
ovarian cancer is an exciting prospect, but this work still needs to be tested in women to see if it can save
cancer is an exciting prospect, but this work still needs to be tested in women to see if it can save lives.
New
research from George Vasmatzis, Ph.D., of the Department of Laboratory Medicine and Pathology
at Mayo Clinic, finds liquid biopsies from blood tests and DNA sequencing can detect a return of
ovarian cancer long before a tumor reappears.
Up to half of women with advanced - stage
ovarian cancer might be cured, compared to the current 20 per cent survival rate, argues Dr. Steven Narod, senior scientist
at Women's College
Research Institute, who calls for a new standard of treatment for women with late - stage
ovarian cancer.
«For decades, women have been treated with a combination of treatment options, resulting in poor prognosis for most women with advanced - stage
ovarian cancer, but there are many survivors as well,» said Dr. Narod, senior scientist
at Women's College
Research Institute.
In their
research, scientists
at Rutgers created animal models that closely resemble the cancerous tumors found in women with
ovarian cancer by injecting tumor tissues obtained from gynecological cancer patients treated at the Cancer Institute into laboratory
cancer by injecting tumor tissues obtained from gynecological
cancer patients treated at the Cancer Institute into laboratory
cancer patients treated
at the
Cancer Institute into laboratory
Cancer Institute into laboratory mice.
Blocking a protein found on the surface of
ovarian cancer cells could prevent or reduce the spread of the disease to other organs, according to new
research at the University of Illinois
at Chicago.
Longer term, they want to quickly diagnose additional
cancer types, including
ovarian and pancreatic
cancers, which are fast - spreading and require early detection for a patient to survive, says Goda, who was recently appointed as a chemistry professor
at the University of Tokyo but will continue his
research with U.C.L.A..
Professor Paul Pharoah, professor of
cancer epidemiology at the Cancer Research UK Cambridge Institute, said: «Our work has found a valuable piece of the puzzle behind ovarian cancer and we hope that our work could eventually form the basis of a genetic test to identify women at greatest
cancer epidemiology
at the
Cancer Research UK Cambridge Institute, said: «Our work has found a valuable piece of the puzzle behind ovarian cancer and we hope that our work could eventually form the basis of a genetic test to identify women at greatest
Cancer Research UK Cambridge Institute, said: «Our work has found a valuable piece of the puzzle behind
ovarian cancer and we hope that our work could eventually form the basis of a genetic test to identify women at greatest
cancer and we hope that our work could eventually form the basis of a genetic test to identify women
at greatest risk.
A
research team led by an award - winning genomicist
at Western University has developed a new method for identifying mutations and prioritizing variants in breast and
ovarian cancer genes, which will not only reduce the number of possible variants for doctors to investigate, but also increase the number of patients that are properly diagnosed.
An
ovarian cancer drug can leak through the blood brain barrier to reach brain tumours and could be an effective treatment for glioblastoma, suggest results presented at the National Cancer Research Institute's (NCRI) Cancer Conference in Liverpool, today (Mo
cancer drug can leak through the blood brain barrier to reach brain tumours and could be an effective treatment for glioblastoma, suggest results presented
at the National
Cancer Research Institute's (NCRI) Cancer Conference in Liverpool, today (Mo
Cancer Research Institute's (NCRI)
Cancer Conference in Liverpool, today (Mo
Cancer Conference in Liverpool, today (Monday).
October 30, 2011 Fat cells in abdomen fuel spread of
ovarian cancer A large pad of fat cells that extends from the stomach and covers the intestines provides nutrients that promote the spread and growth of
ovarian cancer, reports a
research team based
at the University of Chicago in the journal Nature Medicine, published online October 30th, 2011.
A large pad of fat cells that extends from the stomach and covers the intestines provides nutrients that promote the spread and growth of
ovarian cancer, reports a
research team based
at the University of Chicago in the journal Nature Medicine, published online October 30th, 2011.
The
research team confirmed those results by testing the four compounds
at a low dose in mice injected with
ovarian cancer cells.
Offit says that in his clinic, where the panel is already being used in
research studies, he was able to test the daughter of a man with metastatic prostate
cancer and learn that she carried mutations that put her
at higher risk for
ovarian cancer.
Recently, Fisher told the story of their friendship
at an Our Way Forward event, a program created by Tesaro with input from the National
Ovarian Cancer Coalition and the
Ovarian Cancer Research Fund.
•
Cancer prevention: A 2009 review of 51 green tea studies found that sipping three to five cups a day may lower the risks of
ovarian, colorectal, lung, and prostate
cancers, but not breast or other
cancers, says lead author Katja Boehm,
research fellow
at the Center of Integrative Medicine
at the University of Witten / Herdecke in Germany.
«Ten years ago, we would typically re-treat them with the drug wed already used,» says Carol Aghajanian, MD, a medical oncologist and head of the
ovarian cancer chemotherapy research program at the Memorial Sloan - Kettering Cancer C
cancer chemotherapy
research program
at the Memorial Sloan - Kettering
Cancer C
Cancer Center.
Fashion Director Audrey Slater finds 7 irresistible deals
at QVC's annual Super Saturday charity shopping event — feel good while you shop designer duds
at 50 % off retail because best of all, a portion of every sale goes to The
Ovarian Cancer Research Fund!
Kim Kardashian, Kourtney Kardashian, Khloe Kardashian and Kris Jenner attend Super Saturday 13 designer garage sale to Benefit
Ovarian Cancer Research Fund hosted by InStyle Magazine
at Nova's Ark Project in Water Mill, New York on July 31, 2010
Analeigh Tipton - 2014
Ovarian Cancer Research Fund's Legends Gala
at The Pierre Hotel - Arrivals
at Pierre Hotel - New York, United States - Wednesday 5th November 2014